Novel role for retinol-binding protein 4 in the regulation of blood pressure

FASEB Journal

Volumn 29, Issue 8, 2015, Pages 3133-3140

  Kraus, Bettina J ^d   Sartoretto, Juliano L ^b   Polak, Pazit ^e   Hosooka, Tetsuya ^f   Shiroto, Takashi ^b   Eskurza, Iratxe ^g   Lee, Seung Ah ^c   Jiang, Hongfeng ^c   Michel, Thomas ^b   Kahn, Barbara B ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c New York Presbyterian Columbia University Medical Center   (United States)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e BAR ILAN UNIVERSITY   (Israel)

^f KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin II; Endothelial no synthase; Hypertension; Obesity

Indexed keywords

ANGIOTENSIN II; CARBACHOL; INSULIN; NITRIC OXIDE SYNTHASE; RETINOL BINDING PROTEIN 4; SODIUM CHLORIDE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NOS3 PROTEIN, MOUSE; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CAROTID ARTERY; COMPARATIVE STUDY; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ENZYME PHOSPHORYLATION; GENOTYPE; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERTENSION; IN VITRO STUDY; LIPID DIET; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTOLIC BLOOD PRESSURE; VASODILATATION; WEIGHT GAIN; ANIMAL; AORTA; BLOOD PRESSURE; C57BL MOUSE; CARDIOMEGALY; KNOCKOUT MOUSE; MALE; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

MUS;

ANGIOTENSIN II; ANIMALS; AORTA; BLOOD PRESSURE; CARDIOMEGALY; HYPERTENSION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE III; OBESITY; PHOSPHORYLATION; RETINOL-BINDING PROTEINS, PLASMA; VASODILATION;

EID: 84940398841     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.14-266064     Document Type: Article

References (40)

1. Blaner, W. S. (1989) Retinol-binding protein: The serum transport protein for vitamin A. Endocr. Rev. 10, 308-316.
2. Graham, T.E., Yang, Q., Blüher, M., Hammarstedt, A., Ciaraldi, T. P., Henry, R. R., Wason, C. J., Oberbach, A., Jansson, P.-A., Smith, U., and Kahn, B. B. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N. Engl. J. Med. 354, 2552-2563.
3. Yang, Q., Graham, T. E., Mody, N., Preitner, F., Peroni, O. D., Zabolotny, J. M., Kotani, K., Quadro, L., and Kahn, B. B. (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 436, 356-362.
4. Norseen, J., Hosooka, T., Hammarstedt, A., Yore, M.M., Kant, S., Aryal, P., Kiernan, U. A., Phillips, D. A., Maruyama, H., Kraus, B. J., Usheva, A., Davis, R. J., Smith, U., and Kahn, B. B. (2012) Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism. Mol. Cell. Biol. 32, 2010-2019.
5. Meisinger, C., Rückert, I.M., Rathmann, W., Döring, A., Thorand, B., Huth, C., Kowall, B., and Koenig, W. (2011) Retinol-binding protein 4 is associated with prediabetes in adults from the general population: TheCooperativeHealthResearch in theRegion ofAugsburg (KORA) F4 Study. Diabetes Care 34, 1648-1650.
6. Qi, Q., Yu, Z., Ye, X., Zhao, F., Huang, P., Hu, F. B., Franco, O. H., Wang, J., Li, H., Liu, Y., and Lin, X. (2007) Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J. Clin. Endocrinol. Metab. 92, 4827-4834.
7. Lambadiari, V., Kadoglou, N. P. E., Stasinos, V., Maratou, E., Antoniadis, A., Kolokathis, F., Parissis, J., Hatziagelaki, E., Iliodromitis, E. K., and Dimitriadis, G. (2014) Serum levels of retinol-binding protein-4 are associated with the presence and severity of coronary artery disease. Cardiovasc. Diabetol. 13, 121.
8. Van Hoek, M., Dehghan, A., Zillikens, M. C., Hofman, A., Witteman, J.C., andSijbrands, E. J.G. (2008) AnRBP4 promoterpolymorphism increases risk of type 2 diabetes. Diabetologia 51, 1423-1428.
9. Solini, A., Santini, E., Madec, S., Rossi, C., and Muscelli, E. (2009) Retinol-binding protein-4 in women with untreated essential hypertension. Am. J. Hypertens. 22, 1001-1006.
10. Sun, Q., Kiernan, U. A., Shi, L., Phillips, D. A., Kahn, B. B., Hu, F. B., Manson, J. E., Albert, C. M., and Rexrode, K. M. (2013) Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study. Circulation 127, 1938-1947.
11. Park, S. E., Kim, D. H., Lee, J. H., Park, J. S., Kang, E. S., Ahn, C. W., Lee, H. C., and Cha, B. S. (2009) Retinol-binding protein-4 is associated with endothelial dysfunction in adults with newly diagnosed type 2 diabetes mellitus. Atherosclerosis 204, 23-25.
12. Solini, A., Stea, F., Santini, E., Bruno, R. M., Duranti, E., Taddei, S., and Ghiadoni, L. (2012) Adipocytokine levels mark endothelial function in normotensive individuals. Cardiovasc. Diabetol. 11, 103.
13. Bobbert, T., Raila, J., Schwarz, F., Mai, K., Henze, A., Pfeiffer, A. F. H., Schweigert, F. J., and Spranger, J. (2010) Relation between retinol, retinol-binding protein 4, transthyretin and carotid intima media thickness. Atherosclerosis 213, 549-551.
14. Ingelsson, E., and Lind, L. (2009) Circulating retinol-binding protein 4 and subclinical cardiovascular disease in the elderly. Diabetes Care 32, 733-735.
15. Muniyappa, R., Montagnani, M., Koh, K. K., and Quon, M. J. (2007) Cardiovascular actions of insulin. Endocr. Rev. 28, 463-491.
16. Michel, T., and Vanhoutte, P. M. (2010) Cellular signaling and NO production. Pflugers Arch. 459, 807-816.
17. Förstermann, U., and Sessa, W. C. (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33, 829-837, 837a-837d.
18. Gardin JM, Adams DB, Douglas PS, Feigenbaum H, ForstDH, Fraser AG, Grayburn PA, Katz AS, Keller AM, Kerber RE, Khandheria BK, Klein AL, Lang RM, Pierard LA, Quinones MA, and Schnittger I; American Society of Echocardiography. (2002) Recommendations for a standardized report for adult transthoracic echocardiography: a report from the American Society of Echocardiography's Nomenclature and Standards Committee and Task Force for a Standardized Echocardiography Report. J. Am. Soc. Echocardiogr. 15, 275-290.
19. Krege, J.H., Hodgin, J.B., Hagaman, J.R., and Smithies, O. (1995) A noninvasive computerized tail-cuff system for measuring blood pressure in mice. Hypertension 25, 1111-1115.
20. Dantas, A. P. V., Igarashi, J., and Michel, T. (2003) Sphingosine 1-phosphate and control of vascular tone. Am. J. Physiol. Heart Circ. Physiol. 284, H2045-H2052.
21. Stuck, B. J., Lenski, M., Böhm, M., and Laufs, U. (2008) Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase. J. Biol. Chem. 283, 32562-32569.
22. Wongsiriroj, N., Jiang, H., Piantedosi, R., Yang, K. J. Z., Kluwe, J., Schwabe, R.F., Ginsberg, H., Goldberg, I. J., and Blaner, W. S.(2014) Genetic dissection of retinoid esterification and accumulation in the liver and adipose tissue. J. Lipid Res. 55, 104-114.
23. Tan, Y., Sun, L.-Q., Kamal, M. A., Wang, X., Seale, J. P., and Qu, X. (2011) Suppression of retinol-binding protein 4 with RNA oligonucleotide prevents high-fat diet-induced metabolic syndrome and non-alcoholic fatty liver disease in mice. Biochim. Biophys. Acta 1811, 1045-1053.
24. Yu, X., Watts, L., Manchem, P., Monia, B., and Bhanot, S. (2008) Antisense reduction of retinol-binding protein 4 expression in liver and adipose tissues causes robust improvements in insulin sensitivity in diabetic and obese mice. 68th Scientific Sessions Meeting, Abstract 59-LB, http://professional.diabetes.org/Abstracts-Display.aspx?TYP=1&CID=71035.
25. Mallat, Z., Simon, T., Benessiano, J., Clément, K., Taleb, S., Wareham, N. J., Luben, R., Khaw, K.-T., Tedgui, A., and Boekholdt, S. M. (2009)Retinol-bindingprotein 4 and prediction of incident coronary events in healthy men and women. J. Clin. Endocrinol. Metab. 94, 255-260.
26. Graham, T. E., Wason, C. J., Blüher, M., and Kahn, B. B. (2007) Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects. Diabetologia 50, 814-823.
27. Romero, J. C., and Reckelhoff, J. F. (1999) State-of-the-Art lecture: role of angiotensin and oxidative stress in essential hypertension. Hypertension 34, 943-949.
28. Kennedy, A. J., Ellacott, K. L. J., King, V. L., and Hasty, A. H. (2010) Mouse models of the metabolic syndrome. Dis. Model. Mech. 3, 156-166.
29. Quadro, L., Blaner, W. S., Hamberger, L., Van Gelder, R. N., Vogel, S., Piantedosi, R., Gouras, P., Colantuoni, V., and Gottesman, M. E. (2002)Muscle expression of human retinol-binding protein (RBP): suppression of the visual defect of RBP knockout mice. J. Biol. Chem. 277, 30191-30197.
30. Törnwall, M.E., Virtamo, J., Korhonen, P.A., Virtanen, M. J., Taylor, P. R., Albanes, D., and Huttunen, J. K. (2004) Effect of alphatocopherol and beta-carotene supplementation on coronary heart disease during the 6-year post-trial follow-up in the ATBC study. Eur. Heart J. 25, 1171-1178.
31. Cook, N. R., Albert, C.M., Gaziano, J. M., Zaharris, E., MacFadyen, J., Danielson, E., Buring, J. E., and Manson, J. E. (2007) A randomized factorial trial of vitamins C and E and beta carotene in the secondary preventionof cardiovascularevents inwomen:results fromtheWomen's Antioxidant Cardiovascular Study. Arch. Intern.Med. 167, 1610-1618.
32. Brazionis, L., Walker, K. Z., Itsiopoulos, C., and O'Dea, K. (2012) Plasma retinol: a novelmarker for cardiovascular diseasemortality in Australian adults. Nutr. Metab. Cardiovasc. Dis. 22, 914-920.
33. Rhee, E.-J., Nallamshetty, S., and Plutzky, J. (2012) Retinoid metabolism and its effects on the vasculature. Biochim. Biophys. Acta 1821, 230-240.
34. Quadro, L., Blaner, W. S., Hamberger, L., Novikoff, P. M., Vogel, S., Piantedosi, R., Gottesman, M. E., and Colantuoni, V. (2004)The role of extrahepatic retinol binding protein in the mobilization of retinoid stores. J. Lipid Res. 45, 1975-1982.
35. Quadro, L., Blaner, W. S., Salchow, D. J., Vogel, S., Piantedosi, R., Gouras, P., Freeman, S., Cosma, M. P., Colantuoni, V., and Gottesman, M. E. (1999) Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein. EMBO J. 18, 4633-4644.
36. Maier, L. S. (2008) Vitamin A for the heart: progress for cardiac hypertrophy regression? Am. J. Physiol. Heart Circ. Physiol. 294, H588-H589.
37. Chavarria, N., Kato, T. S., Khan, R., Chokshi, A., Collado, E., Akashi, H., Takayama, H., Naka, Y., Farr, M., Mancini, D., and Schulze, P. C. (2012) Increased levels of retinol binding protein 4 in patients with advanced heart failure correct after hemodynamic improvement through ventricular assist device placement. Circ. J. 76, 2148-2152.
38. Farjo, K.M., Farjo, R.A., Halsey, S., Moiseyev, G., and Ma, J.-X. (2012) Retinol-binding protein 4 induces inflammation in human endothelial cells by an NADPH oxidase- and nuclear factor kappa B-dependent and retinol-independent mechanism. Mol. Cell. Biol. 32, 5103-5115.
39. Takebayashi, K., Sohma, R., Aso, Y., and Inukai, T. (2011) Effects of retinol binding protein-4 on vascular endothelial cells. Biochem. Biophys. Res. Commun. 408, 58-64.
40. Vlachopoulos, C., Aznaouridis, K., and Stefanadis, C. (2010) Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 55, 1318-1327.